Flu
Researchers find that influenza has an Achilles’ Heel
Flu epidemics cause up to half a million deaths worldwide each year, and emerging strains continually threaten to spread to humans and cause even deadlier pandemics. A study by McGill University professor Maziar Divangahi published by Cell Press on April 10 in the journal Immunity reveals that a drug that inhibits a molecule called prostaglandin E2 (PGE2) increases survival rates in mice infected with a lethal dose of the H1N1 flu virus. The findings pave the way for an urgently needed therapy that is highly effective against the flu virus and potentially other viral infections.
Thu, 2014-04-10 12:04
Contact Information
Contact:
Cynthia Lee
Organization:
Media Relations Office
Email:
cynthia [dot] lee [at] mcgill [dot] ca
Office Phone:
514 398-6754
Secondary Contact Information
Contact:
Mary Beth O'Leary
Organization:
Media Relations Cell Press/Elsevier
Email:
moleary@cell.com
Office Phone:
+1 617 397 2802
Category:
Source Site:
/newsroom
Classified as:
Resisting the flu
New avenues for influenza control suggested by identification of an enzyme that plays a crucial role in resistance to the infection
Wed, 2014-01-15 14:06
Contact Information
Contact:
Katherine Gombay
Organization:
Media Relations Office
Email:
katherine [dot] gombay [at] mcgill [dot] ca
Office Phone:
514-398-2189
Category:
Source Site:
/newsroom
Classified as: